A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic Eczema
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to investigate the effect of AERODERM (also known as
pitrakinra, AER 001, BAY 16-9996) on Eczema Area and Severity Index (EASI) score in subjects
with moderate to severe atopic eczema